bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely bluebird bio is implementing good security practices.
Read more about the latest issues in cybersecurity
Third-party vendors are an important source of strategic advantage, cost savings and expertise. Yet ...
Spyware is unwanted software, a type of malicious software or malware, designed to expose sensitive ...
Compare bluebird bio's security performance with other companies